Recent advances in diagnostic technologies in lung cancer

키워드

참고문헌 (50)

1. "Annual report of cancer statistics in Korea in 2016" (2016)[URL]
2. 김영철, "The Development of the Korean Lung Cancer Registry (KALC-R)", Tuberculosis and Respiratory Diseases, 82(2), pp.91~93 (2019), 대한결핵및호흡기학회[DOI]
3. 박찬권, "Trends and Updated Statistics of Lung Cancer in Korea", Tuberculosis and Respiratory Diseases, 82(2), pp.175~177 (2019), 대한결핵및호흡기학회[DOI]
4. "Causes of death statistics in 2018" (2018)[URL]
5. 여창동, "Indicators and Qualitative Assessment of Lung Cancer Management by Health Insurance Review and Assessment Service (HIRA) of Korea in 2015", Tuberculosis and Respiratory Diseases, 81(1), pp.19~28 (2018), 대한결핵및호흡기학회
6. Gucalp R, "Harrison’s Principles of Internal Medicine Vol. 1", pp.511~512 (2018), McGraw Hill Educations
7. Horn L, "Harrison’s Principles of Internal Medicine Vol. 1", pp.537~555 (2018), McGraw Hill Education
8. Jameson JL, "Harrison’s Principles of Internal Medicine Vol. 1", pp.662~668 (2018), McGraw Hill Education
9. National Lung Screening Trial Research Team, "Reduced lung-cancer mortality with low-dose computed tomographic screening", N Engl J Med, 365, pp.395~409 (2011)
10. 이종민, "Clinical Characteristics of False-Positive Lymph Node on Chest CT or PET-CT Confirmed by Endobronchial Ultrasound– Guided Transbronchial Needle Aspiration in Lung Cancer", Tuberculosis and Respiratory Diseases, 81(4), pp.339~346 (2018), 대한결핵및호흡기학회
11. Goldberg SB, "Lung cancer brain metastases", Cancer J, 21, pp.398~403 (2015)
12. 송재욱, "Are There Any Additional Benefits to Performing Positron Emission Tomography", Computed Tomography Scans and Brain Magnetic Resonance Imaging on Patients with Ground-Glass Nodules Prior to Surgery?, 2017, pp.80(4), 368~376[DOI]
13. Ettinger DS, "NCCN guidelines insights: non-small cell lung cancer, version 1.2020", J Natl Compr Canc Netw, 17, pp.1464~1472 (2019)
14. 문성미, "Diagnostic Performance of Radial Probe Endobronchial Ultrasound without a Guide-Sheath and the Feasibility of Molecular Analysis", Tuberculosis and Respiratory Diseases, 82(4), pp.319~327 (2019), 대한결핵및호흡기학회[DOI]
15. Sampsonas F, "EBUS: faster, cheaper and most effective in lung cancer staging", Int J Clin Pract, 72 (2018)
16. 김서윤, "Incidence of Fever Following Endobronchial Ultrasound–Guided Transbronchial Needle Aspiration", Tuberculosis and Respiratory Diseases, 80(1), pp.45~51 (2017), 대한결핵및호흡기학회
17. Dong X, "Endobronchial ultrasound-guided transbronchial needle aspiration in the mediastinal staging of non-small cell lung cancer : a meta-analysis", Ann Thorac Surg, 96, pp.1502~1507 (2013)
18. Tournoy KG, "EBUS-TBNA for the diagnosis of central parenchymal lung lesions not visible at routine bronchoscopy", Lung Cancer, 63, pp.45~49 (2009)
19. Gupta A, "The value of using radial endobronchial ultrasound to guide transbronchial lung cryobiopsy", J Thorac Dis, 11, pp.329~334 (2019)
20. 김은진, "Utility of Radial Probe Endobronchial Ultrasound-Guided Transbronchial Lung Biopsy in Diffuse Lung Lesions", Tuberculosis and Respiratory Diseases, 82(3), pp.201~210 (2019), 대한결핵및호흡기학회
21. Mehta AC, "The evolutional history of electromagnetic navigation bronchoscopy : state of the art", Chest, 154, pp.935~947 (2018)
22. Yarmus LB, "Electromagnetic navigation transthoracic needle aspiration for the diagnosis of pulmonary nodules : a safety and feasibility pilot study", J Thorac Dis, 8, pp.186~194 (2016)
23. Gex G, "Diagnostic yield and safety of electromagnetic navigation bronchoscopy for lung nodules : a systematic review and meta-analysis", Respiration, 87, pp.165~176 (2014)
24. DiBardino DM, "Transthoracic needle biopsy of the lung", J Thorac Dis, 7, pp.S304~S316 (2015)
25. Heerink WJ, "Complication rates of CT-guided transthoracic lung biopsy : meta-analysis", Eur Radiol, 27, pp.138~148 (2017)
26. 전민철, "CT-Guided Percutaneous Transthoracic Needle Biopsy Using the Additional Laser Guidance System by a Pulmonologist with 2 Years of Experience in CT-Guided Percutaneous Transthoracic Needle Biopsy", Tuberculosis and Respiratory Diseases, 81(4), pp.330~338 (2018), 대한결핵및호흡기학회
27. Birchard KR, "Transthoracic needle biopsy", Semin Intervent Radiol, 28, pp.87~97 (2011)
28. El-Telbany A, "Cancer genes in lung cancer: racial disparities: are there any?", Genes Cancer, 3, pp.467~480 (2012)
29. Sanger F, "DNA sequencing with chain-terminating inhibitors", Proc Natl Acad Sci U S A, 74, pp.5463~5467 (1977)
30. Kim HJ, "Detection and comparison of peptide nucleic acid-mediated real-time polymerase chain reaction clamping and direct gene sequencing for epidermal growth factor receptor mutations in patients with non-small cell lung cancer", Lung Cancer, 75, pp.321~325 (2012)
31. 이현주, "Comparison of Direct Sequencing, PNA Clamping-Real Time Polymerase Chain Reaction, and Pyrosequencing Methods for the Detection of EGFR Mutations in Non-small Cell Lung Carcinoma and the Correlation with Clinical Responses to EGFR Tyrosine Kinase Inhibitor Treatment", Journal of Pathology and Translational Medicine, 47(1), pp.52~60 (2013), 대한병리학회
32. 박철규, "What is Currently the Best for Adenocarcinoma without Driver Mutation?", Tuberculosis and Respiratory Diseases, 81(3), pp.258~259 (2018), 대한결핵및호흡기학회
33. Garinet S, "Current and future molecular testing in NSCLC, what can we expect from new sequencing technologies", J Clin Med, 7, pp.144~ (2018)
34. Bennett NC, "Next-generation sequencing in clinical oncology: next steps towards clinical validation", Cancers (Basel), 6, pp.2296~2312 (2014)
35. Sanchez-Cespedes M, "Inactivation of LKB1", STK11 is a common event in adenocarcinomas of the lung, 2002, pp.62, 3659~3662
36. Fang R, "Integrative genomic analysis reveals a high frequency of LKB1 genetic alteration in Chinese lung adenocarcinomas", J Thorac Oncol, 9, pp.254~258 (2014)
37. "Partial revision to details on criteria and method of application for medical care benefits" (2017)[URL]
38. Wu Z, "Update on liquid biopsy in clinical management of non-small cell lung cancer", Onco Targets Ther, 12, pp.5097~5109 (2019)
39. Shin S, "Assessment of real-time PCR method for detection of EGFR mutation using both supernatant and cell pellet of malignant pleural effusion samples from non-small-cell lung cancer patients", Clin Chem Lab Med, 55, pp.1962~1969 (2017)
40. Lim SB, "A merged lung cancer transcriptome dataset for clinical predictive modeling", Sci Data, 5, pp.180136~ (2018)
41. 방만석, "Transcriptome analysis of non-small cell lung cancer and genetically matched adjacent normal tissues identifies novel prognostic marker genes", Genes & Genomics, 39(3), pp.277~284 (2017), 한국유전학회[DOI]
42. Gesthalter YB, "Translating the transcriptome into tools for the early detection and prevention of lung cancer", Thorax, 70, pp.476~481 (2015)
43. Silvestri GA, "A bronchial genomic classifier for the diagnostic evaluation of lung cancer", N Engl J Med, 373, pp.243~251 (2015)
44. Inamura K, "Lung cancer : understanding its molecular pathology and the 2015 WHO classification", Front Oncol, 7, pp.193~ (2017)
45. Thorne-Nuzzo T, "A sensitive ALK immunohistochemistry companion diagnostic test identifies patients eligible for treatment with Crizotinib", J Thorac Oncol, 12, pp.804~813 (2017)
46. Scott J. Antonia, "Tumor Immunology and Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer", Tuberculosis and Respiratory Diseases, 81(1), pp.29~41 (2018), 대한결핵및호흡기학회
47. 박하영, "Clinical Characteristics of Korean Patients with Lung Cancer Who Have Programmed Death-Ligand 1 Expression", Tuberculosis and Respiratory Diseases, 82(3), pp.227~233 (2019), 대한결핵및호흡기학회
48. Husain AN, "Guidelines for pathologic diagnosis of malignant mesothelioma 2017update of the consensus statement from the international mesothelioma interest group", Arch Pathol Lab Med, 142, pp.89~108 (2018)
49. Kim T, "Presence of mEGFR ctDNA predicts a poor clinical outcome in lung adenocarcinoma", Thorac Cancer, 10, pp.2267~2273 (2019)
50. Byung Ju Kang, "Circulating Tumor Cell Number Is Associated with Primary Tumor Volume in Patients with Lung Adenocarcinoma", Tuberculosis and Respiratory Diseases, 83(1), pp.61~70 (2020), 대한결핵및호흡기학회[DOI]